Objective
Introduction
Angiotensin II (Ang II) is an important growth regulating factor, both in normal heart development and in hypertrophy resulting from systemic hypertension. 1 Pressure-overloaded hypertrophy is characterised by increases in the accumulation of collagen and other extracellular matrix proteins and by increases in myocyte size and ventricular wall thickness. 2 It is also well known that hypertension may lead to myocardial fibrosis, even before the development of myocardial hypertrophy and that this process will impair left ventricular function, especially during diastole. Myocardial fibrosis is also an important contributor to ventricle dysfunction in chronic heart failure. Cardiac fibroblasts are responsible for synthesising the majority of extracellular matrix proteins and the presence of a high number of Ang II receptors has been demonstrated. [3] [4] [5] In vitro,Ang II induces a stimulation of collagen secretion and production in cultures of cardiac fibroblasts through Ang II subtype 1 (AT 1 )-receptors. 6 Ang II infusions, at pressor or subpressor doses, also induce collagen and fibronectin. 7 Reducing endogenous Ang II levels with angiotensin-converting enzyme (ACE) inhibition attenuates the myocardial accumulation of collagen and fibrotic tissue in spontaneously hypertensive rats, reverses myocardial fibrosis and improves myocardial diastolic stiffness. 5, 8, 9 Integrins, a widely expressed family of cell surface adhesion receptors, are important regulators of the intimate interactions between myocytes, extracellular matrix proteins and cytoskeletal components in the heart. 10 In an in vitro assay, using three-dimensional collagen gels, β 1 -integrin mediates gel contraction by neonatal heart fibroblasts by various growth factors. 11 Through interaction of the cardiac fibroblasts in collagen gels with the collagen via specific integrin receptors, the gel is contracted. 12 In vivo, cardiac fibroblasts interact with myocytes to regulate the mechanical properties of the heart. 13 Similarly, three-dimensional collagen gels in vitro re-establish the interaction of fibroblasts with their collagen matrix. 14, 15 In vitro, Ang II (100 nmol/L) stimulates the collagen gel contraction in adult rat cardiac fibroblasts plated in a threedimensional collagen gel in a Dulbecco's Modified Eagle's Medium (DMEM) medium in the presence of 5% foetal bovine serum (FBS). 16 Most of the classical actions of Ang II are mediated via AT 1 -receptors, whereas AT 2 -receptor stimulation may cause opposing effects. 17 Ang II is rapidly metabolised in the circulation, the aminopeptidases A and N sequentially removing amino-acids from the N-terminus of Ang II to form angiotensin III (Ang III) and angiotensin IV (Ang IV). 17 Of these metabolites, Ang III binds with the highest affinity to AT 1 -receptors (10-fold lower affinity than Ang II) and Ang IV binds weakly, with affinities of 100-to 1,000-fold less. 17 An AT 4 -receptor in the heart, with a high selectivity for Ang IV and a 10-fold lower affinity for Ang III, has also been described. 17 The aim of the present study was to investigate whether collagen gel contraction in adult rat cardiac fibroblasts can be performed in DMEM without FBS, and whether Ang II (1-8) and its fragments Ang III,Ang IV,Ang II (1-7),Ang II (4-8),Ang II (5) (6) (7) (8) or Ang II (1) (2) (3) (4) can stimulate collagen gel contraction in cardiac fibroblasts in serum-free conditions.The possible contributions of the AT 1and AT 2 -receptor antagonists, of the Ang III receptor antagonist and of the Ang IV receptor antagonist are studied using telmisartan, PD 123319, des-Asp 1 -Ile 8 -Angiotensin II and Nle 1 -Leu 3 -angiotensin IV, respectively.
Materials and methods

Materials
Ang II, III, IV, and Ang II (1-7), Ang II (4-8), Ang II (5) (6) (7) (8) 
Isolation of cardiac fibroblasts
All animal procedures were in accordance with the laws, regulations and administrative provisions of the Member States of the European Community (Council Directive 86/609/EEC of November 24, 1986 ) regarding the protection of animals for experimental and other scientific purposes. This research protocol was also approved by the Ethical Committee for Animal Experiments of the Katholieke Universiteit Leuven (K.U.Leuven), Belgium.
Cardiac ventricular fibroblasts were obtained from male Wistar rats, seven to eight weeks old and weighing about 200 g, using a slightly modified isolation procedure as described by Brilla et al. 18 In brief, rats were heparinised (625 units/ 100 g body weight) and anaesthetised intraperitonially with nembutal 50 mg/100 g body weight.
The heart was removed and placed immediately in sterile Joklik's medium.The extirpated hearts were allowed to eject any residual blood and the aorta was cannulated. A syringe, filled with a few ml of basic salt solution containing NaCl 130 mM, KCl 3 mM, KH 2 PO 4 1.2 mM, MgSO 4 1 mM, CaCl 2 1.25 mM, glucose 10 mM, N-(2-hydroxyethyl) piperazine-2'-(2-ethanesulfonic acid) (HEPES) 10 mM, pH 7.2 was placed in the cannula to rinse the blood out of the heart.The hearts were then perfused via the ascending aorta according to the Langendorff method 19 with Joklik's medium for 5 minutes, then by recirculating Joklik's medium containing 0.02% collagenase A and 2% BSA for 35 minutes with a flow of 5 ml/minute. Thereafter, the atria and vessels were removed and the ventricular tissue placed in Joklik's medium containing 1% BSA and 0.01% collagenase A for an additional 10 minutes (37°C). The tissue was then minced and filtered through a 200 µM mesh net.
Cell cultures
The coarse cell/disintegrated tissue suspension was allowed to settle for 15 minutes, and the supernatants then centrifuged at 350 g for 10 minutes. The pellet was resuspended in DMEM, supplemented with 10% FBS and 1% of penicillin/streptomycin solution, and seeded in a 80 cm 2 tissue culture flask. The cell cultures were then preincubated at 37°C in humidified air (humidity 95%) with 5% CO 2 for 4 hours. The medium with unattached cells was then aspirated and fresh DMEM supplemented with 10% FBS and penicillin/streptomycin added. The cultures were examined daily, using phase-contrast microscopy. The medium was replaced every two to three days and the cells were grown to confluence and then passaged with trypsin-EDTA. Under the above mentioned conditions of isolation, coronary smooth muscle and endothelial cells are already rarely seen in the primary cultures. Myocytes do not survive the isolation method since oxygen is not provided. In the present study, only cardiac fibroblasts from passage two were used. For the second passage, cells were transferred to 6-well dishes in DMEM with 10% FBS at a density of 2,600 cells/dish for three days until confluency.
The cells were then harvested, washed and 100,000 cells added to the hydrated collagen in 24-wells.
Collagen gel contraction assay or contraction of a hydrated collagen lattice
BSA treatment of wells: 500 µl of 1% BSA in 10 mM phosphate buffered saline (138 mM NaCl and 2,7 mM KCl) pH 7.4 (PBS) was added to each well, incubated at 37°C for at least 2 hours and twice washed with PBS.
Preparation of collagen solution
Collagen gels were prepared from rat tail collagen type I. A 12.55 ml collagen solution was prepared by mixing 4.25 ml collagen in 0.02 N acetic acid (4.38 mg/ml), 1.65 ml 100 mM NaOH, and 1.25 ml 10 x MEM and 5.4 ml of bidistilled water was added to obtain a final concentration of 1.5 mg collagen per ml. The solution was kept on ice until addition of cells.
Preparation of fibroblast-induced collagen suspension
Five-hundred µl of this collagen solution was added to each BSA-treated well. Cardiac fibroblast in DMEM (100,000 cells) were then added to this collagen solution in the wells and incubated for 1 hour at 37°C for polymerisation.
Subsequently, 1 ml of DMEM containing no FBS was added to each well, together with or without test compounds such as angiotensins, telmisartan, PD 123319, des-Asp 1 -Ile 8 -angiotensin II or Nle 1 -Leu 3 -angiotensin IV. These media were not replenished with these products during the three days of incubation.
Preparation of floating gels
The gels were detached spontaneously from the sides and bottom of the wells and placed in a tissue culture incubator for one, two and three days.
Densitometric analysis of the collagen gel area
The area of the collagen gel in each well was determined by a densitometric analysis, using a Sharp scanner JX-325 and a Software Image Master (Amersham Pharmacia Biotech, Roosendaal, The Netherlands).
A decrease in the gel area induced by the cardiac fibroblasts corresponds to a stimulation of the contraction of the collagen gel lattice. 16 Optimal conditions for collagen gel contraction by adult cardiac fibroblasts were obtained with 100,000 cells incubated for 1 up to 3 days. 20
Measurement of DNA content in the gels
After the collagen gels had been cultured with cardiac fibroblasts for three days, the medium was aspirated.The gels were solubilised by the addition of 200 µl collagenase A (1 mg/ml in 20 mM HEPES buffer pH 7.2, containing 150 mM NaCl and 10 mM Na-acetate).After incubation for 1 hour, the cell suspension was pipetted in an Eppendorff tube and centrifuged at 340 g for 5 minutes.The supernatant was discarded and 50 µl EDTA (2 mM) added to the pellet.
DNA was measured fluorimetrically with the Hoechst dye 33258 (bisbenzimide) using an excitation wavelength of 360 nm and an emission wavelength of 460 nm, 21 according to manufacturer's instructions (Bio-Rad Laboratories, Hercules, California, USA).
H-Thymidine incorporation in the gels
After the collagen gels had been cultured with cardiac fibroblasts for two days, 1 ml 3 H-thymidine (1 mCi/ml) per 1 ml of medium was added and further incubated for 18 hours.The medium was then aspirated and the gels washed three times with 1 ml of 0.01 M phosphate buffered saline (NaCl [138 mM], KCl [2.7 mM], pH 7.4, plus 50 µM thymidine).
The gels were then solubilised by the addition of 200 µl collagenase A.After incubation for 90 minutes, the cell suspension was pipetted into an Eppendorff tube and centrifuged at 2,000 g for 10 minutes.
The supernatants were discarded, 500 µl NaOH (0.25 N) added to the pellet, and 500 µl of the resuspended material added to 5 ml scintillation fluid. The Eppendorff tube was rinsed with 250 µl NaOH and the rinsate also added to the scintillation fluid. The radioactivity was measured in a liquid scintillation counter (Tri-Carb Model A, Canberra Packard, Benelux NV) and the 3 H-thymidine incorporation was expressed in dpm/10 6 cells.
Statistical analysis
Values are expressed as means+SEM.The statistical methods used were repeated measures analysis of variance (Tukey's). A p-value < 0.05 was considered statistically significant.
Results
Effect of Ang II on collagen gel contraction
As shown in Figure 1 , Ang II dose-dependently stimulated collagen gel contraction in adult rat cardiac fibroblasts after one, two and three days of incubation in serum-free conditions, as compared with control. Addition of 100 nmol/L Ang II increased the collagen gel contraction in cardiac fibroblasts after one, two and three days of incubation by 15.3+3.5%, 19.8+3.8% and 24.2+3.5%, respectively. 
Effect of Ang II receptor antagonists on Ang II-stimulated collagen gel contraction
The addition of telmisartan and PD 123319, alone or together, did not affect the collagen gel contraction in cardiac fibroblasts. Addition of telmisartan (10 -7 M) significantly blocked the Ang II (10 -7 M)-induced increase in collagen gel contraction after one, two and three days of incubation ( Figure  2 ). When the Ang II AT 2 -receptor antagonist, PD 123319 (10 -7 M), was added to the fibroblast cultures, it had no effect on the Ang II-induced increase in collagen gel contraction.
Effect of Ang II-fragments on collagen gel contraction
100 nmol/l Ang III also stimulated collagen gel contraction, while Ang IV and Ang II (1-7), Ang II (4-8), Ang II (5-8) and Ang II (1-4) did not affect collagen gel contraction in cardiac fibroblasts incubated for one, two and three days in serumfree conditions ( Table 1) .
Effect of Ang III receptor antagonism on collagen gel contraction
The Ang III-stimulated collagen gel contraction by cardiac fibroblasts was completely abolished by the Ang III receptor antagonist, des-Asp 1 -Ile 8angiotensin II, and by telmisartan ( Figure 3 ). des-Asp 1 -Ile 8 -angiotensin II, however, had no effect on Ang II-induced collagen gel contraction by cardiac fibroblasts.
No effect of the Ang IV antagonist, Nle 1 -Leu 3angiotensin IV on collagen gel contraction by cardiac fibroblasts was observed under control conditions, or after stimulation with Ang II or Ang III.
DNA content and 3 H-thymidine incorporation in the collagen gel matrix inocculated by cardiac fibroblasts
The DNA content and 3 H-thymidine incorporation in the collagen gel matrix inocculated by cardiac fibroblasts for three days averaged 393+33 ng/well and 13440+1660 dpm/10 6 cells (n=3), respectively and was not affected by Ang II, Ang III, Ang IV or Ang II (1-7), Ang II (4-8), Ang II (5) (6) (7) (8) or Ang II (1-4) at a concentration of 10 -7 M.
Discussion
The present study shows that, in serum-free conditions, Ang II stimulates the contraction of adult rat cardiac fibroblasts plated in a three-dimensional collagen gel lattice.This effect is blocked by the Ang II AT 1 -receptor antagonist, telmisartan, but not by the AT 2 -receptor antagonist, PD 123319. It should be mentioned that, during contraction, floating collagen matrices develop into a resting or mechanically-relaxed tissue, whose cells have morphological and proliferative features resembling scar (or dermis), whereas anchored or attached collagen gels develop into an active, stressed tissue resembling granulation tissue. 22 Stress relaxation, on the other hand, represents the transition from granulation tissue to scar. 22 In three-dimensional cultures of neonatal cardiac fibroblasts, Burgess et al. 15 have reported that Ang II influences the ability of these fibroblasts to contract three-dimensional collagen gels and the regulation of membrane-bound integrins. Ang II induces three-dimensional collagen gel contraction by neonatal cardiac fibroblasts; [23] [24] [25] cells which produce the adhesion protein, osteopontin, which mediates Ang II-regulated remodelling processes involving cardiac fibroblasts. [23] [24] [25] Previously, we 16 have already shown that, in vitro,Ang II stimulates collagen gel contraction in adult rat cardiac fibroblasts plated in a threedimensional collagen gel in a DMEM medium in the presence of 5% FBS. The present data show that Ang II also exerts this stimulatory action on collagen gel contraction by adult cardiac fibroblasts in the absence of FBS, thus without any interference of substances present in FBS patches.
Besides Ang II, Ang III also stimulates, in serumfree conditions, collagen gel contraction in adult cardiac fibroblasts plated in a three-dimensional collagen lattice.This effect is blocked by the Ang III receptor antagonist des-Asp 1 -Ile 8 -angiotensin II 17, 26, 27 and by telmisartan, but not by PD 123319. However, des-Asp 1 -Ile 8 -angiotensin II has no effect on Ang II-induced collagen gel contraction. Other Ang II fragments (1-7), (4-8), (5) (6) (7) (8) , (1) (2) (3) (4) and Ang IV do not affect collagen gel contraction in cardiac fibroblasts in serum-free conditions. All tested angiotensins have no effect on the DNA-content or the 3 H-thymidine incorporation of the collagen gels inocculated by cardiac fibroblasts.
Ang II is recognised as the principle active peptide of the renin-angiotensin system (RAS), exerting effects on fluid and electrolyte homeostasis, and cardiovascular control, including neural and long-term trophic effects. 17 However, other angiotensin peptides, such as Ang III or Ang IV, may have specific actions. 17 Ang III is a naturally-occurring heptapeptide, 28 which is formed as a result of N-terminal degradation of Ang II by aminopeptidase A. 29 An alternate pathway consists of conversion of angiotensin I to des-Asp 1angiotensin I by aminopeptidase A, 30 followed by subsequent conversion of des-Asp 1 -angiotensin I to Ang III by converting enzyme. 31, 32 In the present study we have shown that Ang II, as well as Ang III, stimulates collagen gel contraction by adult rat cardiac fibroblasts; the effect of Ang II is blocked by telmisartan but not by des-Asp 1 -Ile 8 -angiotensin II, while the effect of Ang III is blocked by des-Asp 1 -Ile 8 -angiotensin II and by telmisartan. The stimulation of collagen gel contraction by rat cardiac fibroblasts by Ang II as well as by Ang III is blocked by the AT 1 -receptor antagonist, telmisartan. Thus, our data suggest that the stimulatory effect of Ang III is mediated by the same subtype of angiotensin receptor as Ang II, and that telmisartan blocked Ang II as well as the receptors responsible for the action of Ang III. In cultured rat aortic endothelial cells, the Ang II and Ang III-induced mRNA expression of plasminogen activator inhibitor-1 and tissue factor is also inhibited by losartan. 33 However, in conscious rats, the pressor effect of Ang III, but not of Ang II, is antag-onised by Sar,Ile-angiotensin II, a selective antagonist of Ang II, indicating that the pressor action of Ang III appears to be mediated through a different subtype of angiotensin receptors. 34 Ang III is equipotent with Ang II in aldosterone-stimulating activity and in suppressing renin release in animals as well as in humans, but has only 20% of the pressor activity of Ang II. [35] [36] [37] It has also been shown that Ang II increases TGF-β 1 gene expression and fibronectin production in cultured rat mesangial cells and renal interstitial fibroblasts, the main effector cells in glomerular and interstitial fibrosis, respectively, 38 suggesting that Ang III can contribute to matrix accumulation. In renal interstitial fibroblasts, Ang III also induces c-fos gene expression, suggesting a potential role of Ang III in the control of cell proliferation. 38 The mechanism by which Ang II or Ang III induces stimulation of three-dimensional gels populated with cardiac fibroblasts, however, is not known. Ang II can stimulate either the locomotion of fibroblasts in the gel or the contraction of fibroblasts (or a subpopulation that contains myofibroblasts) or both. It is known that Ang II stimulates the locomotion of different types of cells. 39, 40 It is not known whether Ang II can stimulate gel contraction by the induction of the contraction of cardiac fibroblasts. However,Ang II has been found to induce the secretion by fibroblasts of transforming growth factor-β 1 , which is the most potent inductor of tissue fibrosis and also induces the differentiation of fibroblasts to myofibroblasts containing α-smooth muscle actin. [41] [42] [43] Our control cultures of adult rat cardiac ventricular fibroblasts contain 14% myofibroblasts containing α-smooth muscle actin. 44 Thus, in the current study, gels contain 14% myofibroblasts at the start of the experiment. It is possible that Ang II or Ang III can further increase the proportion of myofibroblasts in the gel during incubation. Therefore, we suggest that the Ang II-or Ang III-induced contraction of gels populated with fibroblasts can be a result of both the locomotion of fibroblasts and the contraction of myofibroblasts. It has indeed been found that locomotion of cells results in traction force. These forces can be visualised by the creation, in the presence of cells, of wrinkles on thin distortable sheets of silicone rubber. 45 The strength of cellular traction differs greatly, however, between different cell types 45 (e.g. Table 1 Collagen gel contraction by adult rat cardiac fibroblasts treated with vehicle (control),Ang IV or Ang II (1-7), Ang II (4-8), Ang II (5) (6) (7) (8) and Ang II (1-4) (10 -7 M) for one, two or three days. fibroblasts exert forces much larger than those actually needed for the locomotion). This strong traction rearranges the collagen gel. 45 The ability of cardiac fibroblasts to contract the collagen gel in the presence of Ang II or Ang III can thus be altered by antagonists of Ang II or Ang III receptors, implying that Ang II and its metabolite,Ang III, are important in regulating this function of the cardiac fibroblasts. Enhanced remodelling of the extracellular matrix by Ang II treatment of cardiac fibroblasts in the collagen gel system 15 implies that Ang II may, at least partly, be responsible for the dramatic reorganisation of interstitial collagen observed in hypertensioninduced hypertrophy. 15, 46 Indeed, elevated Ang II levels, seen by cardiac fibroblasts in some forms of renovascular hypertension, 15 might stimulate collagen synthesis because of the enhanced metabolic action of the cardiac fibroblasts observed in hypertrophy resulting from hypertension or pressure overload.Ang II and its metabolite Ang III may impose an increased resistance to the contracting myocytes in the heart by causing fibroblasts to contract the extracellular matrix around the contracting myocytes.
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In conclusion, our data show that Ang II and its metabolite Ang III stimulate collagen gel contraction by adult rat cardiac fibroblasts, in serum-free conditions.The Ang II-stimulated collagen gel contraction is completely blocked by telmisartan, but not by des-Asp 1 -Ile 8 -angiotensin II, while the Ang III-induced stimulation of collagen gel contraction is abolished by des-Asp 1 -Ile 8 -angiotensin II, as well as by telmisartan.These data suggest that telmisartan can block AT 1 -receptors and the receptors responsible for the action of Ang III, while des-Asp 1 -Ile 8 -angiotensin II blocks the receptors responsible for the action of Ang III but not the Ang II receptors in cardiac fibroblasts. However, a definite proof of the existence of Ang III receptors in cardiac fibroblasts has not yet been provided. Trabrizchi et al. 34 have, however, reported the existence of a subclass of angiotensin receptors activated by Ang III in vascular smooth muscle. The cellular mechanism(s) by which this contraction is stimulated by Ang II and Ang III has to be elucidated further, as well as the biological significance of Ang III in cardiac (myo)fibroblasts and the definite proof of Ang III receptors in these cells.
